News

News & Veranstaltungen

Orthos VITROS® High Sensitivity Troponin I Assay zur Herzinfarkt-Diagnose erhält CE-Zeichen und ist ab sofort in den EU-Ländern erhältlich

Apr 16, 2019

Assay der nächsten Generation hilft bei der schnelleren und genaueren Diagnose von Herzinfarkten und läuft auf dem neuesten Analysegerät des Unternehmens, dem VITROS® XT 7600 Integrated System.

VITROS® XT MicroSlide von Ortho Clinical Diagnostics erhält CE-Zeichen: Erstmals wurde die MicroSlide-Technologie um eine Funktion erweitert, die multiples Testen erlaubt

Mar 13, 2019

Orthos VITROS® XT MicroSlide wird unterstützt von DIGITAL CHEMISTRY™, einer digitalen bildgebender Technologie, die wesentlich mehr Informationen aus jedem Test herauslesen kann als dies zuvor möglich war, wodurch die Leistung gesteigert, im Labor zeit- und platzsparend gearbeitet werden kann, die Produktivität erhöht wird und weniger Patientenproben für das Testen erforderlich sind.

Robert Yates Named Next Chairman and CEO of Ortho Clinical Diagnostics

Jan 28, 2019

Ortho has appointed Robert Yates as chairman and chief executive officer effective February 12, 2019. Robert Yates will succeed Dr. Martin Madaus, who is retiring after serving as chairman and CEO of Ortho since June 2014.

Ortho Clinical Diagnostics Launches New VITROS® Anti-T. cruzi Assay

Oct 2, 2018

Ortho Clinical Diagnostics (Ortho) has announced the introduction of its next-generation Anti-T. cruzi assay, with CE Mark approval and approval for use in Mexico. 

Das VITROS® XT 7600 Integrierte System von Ortho Clinical Diagnostics erhält CE-Kennzeichnung Ein innovativer Ansatz für die klinischen Labors

Jul 24, 2018

Ortho Clinical Diagnostics gab heute bekannt, dass es die CE-Kennzeichnung für das integrierte System VITROS® XT 7600 erhalten und auf den Markt gebracht hat.

Ortho Clinical Diagnostics bringt neue MicroTip Partnership Assays für Diabetes, Herz- und Nierenfunktion in Zusammenarbeit mit Diazyme Laboratories, Inc. auf den Markt

Jul 17, 2018

Ortho Clinical Diagnostics bringt neue MicroTip Partnership Assays für Diabetes, Herz- und Nierenfunktion in Zusammenarbeit mit Diazyme Laboratories, Inc. auf den Markt

Ortho ‘Laser-Focused for Success’

Jun 22, 2018

Ortho Chairman and CEO Martin Madaus tells Ortho’s successful carve-out, growth story to PM360.

ISBT Satellite Symposium Co-Hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics

Jun 1, 2018

Ortho will host a satellite symposium, co-sponsored with Quotient Limited (QTNT), titled “Responding to the Challenges of Resource Constraints in Transfusion Diagnostics.” during the 35th International Congress of the International Society of Blood Transfusion (ISBT). 

Edison Awards Recognize Ortho Clinical Diagnostics’ VITROS® NEPHROCHECK® Test for Best New Product

Apr 12, 2018

Ortho Clinical Diagnostics has been selected for a gold-level Edison Award™ in the Best New Product Awards™ category for its VITROS® NEPHROCHECK® Test. VITROS NEPHROCHECK is the first fully automated risk assessment tool for predicting acute kidney injury (AKI), a serious and potentially fatal condition affecting hospital patients worldwide.

A New and Novel Method for the Measurement of Alanine Aminotransferase (ALT) from Ortho Clinical Diagnostics Is Now Available

Dec 19, 2017

Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced the launch of VITROS® ALTV Slides, a new and novel method for the measurement of alanine aminotransferase (ALT), a key liver function enzyme found in serum and plasma, utilizing dry slide technology. 

Ortho’s VITROS® NEPHROCHECK™ Wins International Award for 'Outstanding Innovation'

Nov 28, 2017

Ortho’s VITROS® NEPHROCHECK™ Wins International Award for 'Outstanding Innovation'

5 Signature Moves from a CEO Who Loves Pushing Limits

Nov 20, 2017

Dr. Martin Madaus speaks to Huffington Post about why he recommends running “The Beast,” how to build social capital and how to manage a successful corporate carveout while maintaining steady growth.

The Future of Optics Innovation

Nov 20, 2017

Ray Jakubowicz, Innovation Fellow at Ortho, shared his perspective on the future of optics, photonics and imaging research, in a recent video by NY State’s Empire State Development project.

Leading ICU Physician Describes Benefit of Risk Analysis, Prevention Measures, in Acute Kidney Injury test

Nov 30, 2017

A new article in the health care industry journal The Pathologist describes how the biomarkers in Ortho’s VITROS® NEPRHOCHECKTM  assay work to detect risk of acute kidney injury.  

Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF Diagnostics

Oct 11, 2017

EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body Now Available on Ortho’s VITROS® 4600 and VITROS® 5600 

Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology and Demonstrate Its Entire Transfusion Medicine Portfolio at the 2017 AABB Annual Meeting

Oct 2, 2017

Industry Workshop to Address Clinical Outcomes of Titration Studies Using ID-MTS™ Gel Test Method 

New NephroCheck® Test Outcomes Data Show Significant Reduction in Kidney Injury, Hospital Stay

Sep 25, 2017

RANDOMIZED CONTROL TRIAL REPORTS 66% REDUCTION IN MODERATE TO SEVERE AKI; 5-DAY REDUCTION IN TOTAL HOSPITAL STAY

“As analyzers evolve, so does transfusion medicine,” an MLO article by Ortho’s Fernando Chaves, MD.

Sep 21, 2017

Learn more about automation and the recent flowering of innovation in blood banking.

Ortho Receives Prestigious ‘Services Excellence’ Award in India

Sep 20, 2017

Recognition is the latest in a string of No. 1 ratings and rankings for holistic Ortho Care™ Support Program.

FDA Approves Two Ortho Clinical Diagnostics Specialty Hepatitis B Assays

Sep 14, 2017

Approval exemplifies Ortho’s commitment to expand menu while streamlining lab operations .

FDA Licenses ORTHO™ Sera designed for Extended Phenotype Testing for Use with Ortho ID-MTS™ Gel Card Technology

Aug 28, 2017

ORTHO™ Sera is the only comprehensive menu of antisera for extended antigen phenotyping available in a gel testing format in the U.S.

Martin Madaus Discusses Ortho's Growth Story on CNBC’s Squawk Box

Aug 10, 2017

How to Manage a Large, Complex Corporate Carve-Out Well: Ortho CEO Dr. Martin Madaus on ​CNBC's Squawk Box

Ortho Clinical Diagnostics kündigt eine globale Vereinbarung mit B.R.A.H.M.S zur Bereitstellung des PCT-Assays für ihre Kunden an

Jul 31, 2017

Der Procalcitonin-Assay spielt eine entscheidende Rolle bei Sepsis und septischem Schock und unterstützt die Kliniker bei der Beurteilung und Behandlung ihrer Patienten

Ortho Clinical Diagnostics Awarded Distinguished #1 Ranking for Service Performance for 2nd Year in a Row

Jul 27, 2017

In Vitro Diagnostics Industry Rankings Published by ServiceTrak™

 

Ortho Clinical Diagnostics to Present 10 Scientific Posters, Seven Products at AACC

Jul 26, 2017

Activities at the annual meeting of American Association for Clinical Chemistry will demonstrate Ortho’s focus on immunodiagnostics and acute kidney injury

Ortho Clinical Diagnostics erhält CE-Kennzeichnung für VITROS® Insulin-Reagenz & -Kalibratoren

Jul 21, 2017

Der Assay wird im dritten Quartal in allen Ländern, in dem die CE-Kennzeichnung anerkannt wird, kommerziell verfügbar sein

Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury Risk, Immunoassay Development at EUROMEDLAB Athens 2017

Jun 12, 2017

Sponsored educational sessions and product demonstrations at IFCC’s EUROMEDLAB Athens conference for lab professionals

Ortho Clinical Diagnostics VITROS® NephroCheck® Test for Prediction of Acute Kidney Injury Cleared, Available in Europe

Jun 6, 2017

AKI, the sudden loss of kidney function, can develop without warning and potentially lead to kidney failure and death. Known as a silent killer, AKI is as common and twice as deadly as a heart attack.
Learn more  

Ortho Chairman and CEO Martin Madaus on Innovation Within the In Vitro Diagnostics Industry: It’s a Decathlon

May 16, 2017

t’s not a sprint, it’s a decathlon. Ortho Chairman and CEO Martin Madaus on innovation within the in vitro diagnostics industry.

Edison Awards Recognize Ortho Clinical Diagnostics for Outstanding Product Innovation

Apr 21, 2017

Ortho Clinical Diagnostics has been awarded an Edison Award™ for Global Product Innovation, for its ORTHO VISION® Platform.

Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical for NephroCheck Test

Mar 13, 2017

Agreement gives Ortho expanded distribution rights in Europe for the NephroCheck Test on the ASTUTE140 platform. 

Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service

Feb 27, 2017

Ortho Care™ Support Program Recognized As Best-in-Class Service and Support for Hospitals, Hospital Networks, Blood Banks & Labs

Ortho Clinical Diagnostics Submits VITROS® Immunodiagnostic Products HIV Combo Assay to FDA for Review; Applies to Expand Use of Specialty Hepatitis B Assays

Feb 23, 2017

Latest submissions exemplify Ortho’s commitment to expand menu while streamlining lab operations 

Ortho Clinical Diagnostics Recognized with Two Global Business Excellence Awards

Feb 2, 2017

ORTHO VISION® Analyzer Wins International Awards for ‘Outstanding Innovation’ and ‘Outstanding Product/Service’

 

Ortho Clinical Diagnostics Celebrates 1,000 Installations of the ORTHO VISION® Platform Worldwide

Jan 24, 2017

This accomplishment is recognition of the ORTHO VISION® platform’s value to customers, and represents faster growth than Ortho’s previous products in this space.

Ortho’s Alex Socarrás is Featured in an Exclusive Radio Interview with El Microscopio

Dec 19, 2016

Alex Socarrás discusses our strategy, new products, our customer focus and trends in the clinical laboratory space in Latin America and worldwide.

Marion General Hospital Addresses Growing Pressures with Lab Data Management from Ortho Clinical Diagnostics

Sep 6, 2016

A Recent Video on Customer Experience of Ortho Clinical Diagnostics’ Lab Data Management Solution at Marion General Hospital

Holistic Support Program Offers Guidance for Labs, Blood Banks

Aug 15, 2016

"This type of support is now more critical than ever," said Ortho’s Alex Socarrás in a recent article in CLP Magazine.

Ortho Clinical Diagnostics Featured in Clinical Lab Products

Aug 9, 2016

Ortho Clinical Diagnostics was featured in a recent article in Clinical Lab Products magazine

Ortho Clinical Diagnostics Announces Ortho Care

Aug 2, 2016

Best-in-Class Service and Support Program for Hospitals, Hospital Networks, Blood Banks and Labs

Ortho Clinical Diagnostics Highlighted in Medical Lab Observer

Aug 1, 2016

Ortho will present seven scientific posters on its assays and display six products at its booth at the 2016 AACC annual meeting.

Ortho Clinical Diagnostics to Present Seven Scientific Posters, Six Products at AACC

Jul 25, 2016

Ortho will present seven scientific posters on its assays and display six products at its booth at the 2016 AACC annual meeting.

Ortho Clinical Diagnostics Receives Coveted #1 Ranking for Service Performance

Jul 19, 2016

Ortho Clinical Diagnostics announced that it was ranked higher than any other company for overall service performance by an OEM in the in vitro diagnostics industry.

Karen Davis-Fleischer, vice president Business Fields at Ortho, was featured in a recent article in Clinical Lab Products

Jul 13, 2016

Karen Davis-Fleischer, VP Business Fields at Ortho, was featured in a recent article in Clinical Lab Products

ORTHO VISION® Analyzer Named Innovation Celebration Award Winner at Premier’s Annual Meeting

Jun 23, 2016

Ortho Clinical Diagnostics today announced that its ORTHO VISION® Analyzer has been recognized with a 2016 Innovation Award by members of Premier, Inc.

Ortho Clinical Diagnostics erhält CE-Kennzeichen für VITROS® Immunodiagnostic HIV Combo Test

Jun 21, 2016

Ein neuer Test erweitert die Palette von Infektionskrankheiten; er wird im Juni in Europa und in anderen Ländern, die das CE-Kennzeichen anerkennen, zum Kauf erhältlich sein

Beckman Coulter and Ortho Clinical Diagnostics Announce Strategic Relationship to Deliver Infectious Disease Testing Menu to Very High-Volume Labs

Jun 8, 2016

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs

Ortho Clinical Diagnostics and Beckman Coulter Strategic Relationship Highlighted in CAP TODAY

Jun 8, 2016

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs

Ortho Clinical Diagnostics Announces Availability of ORTHO™ Sera Extended Phenotype Testing on ORTHO VISION® Analyzer for BioVue® Cassettes

Apr 28, 2016

Ortho Clinical Diagnostics today announced that ORTHO™ Sera, a fully automated solution for extended antigen phenotyping, is now available on the ORTHO VISION® Analyzer.

Ortho Chairman and CEO Martin Madaus Featured in FierceMedicalDevices

Apr 25, 2016

Ortho’s Chairman and CEO speaks about the Company’s progress as an independent company in this Q&A interview with FierceMedicalDevices

Ortho Chairman and CEO Martin Madaus Featured in Medical Laboratory Observer

Dec 1, 2015

Ortho's Chairman and CEO speaks about the Company's pioneering spirit and how it is driving forward as a global partner for clinical laboratories and transfusion medicine.

Terre Haute Regional Hospital Becomes First to Install the ORTHO VISION™ Analyzer

Nov 12, 2015

Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION™ Analyzer.

Ortho Clinical Diagnostics Featured in The Kansan

Nov 6, 2015

Newton Medical Center is the first hospital in the U.S. to order new transfusion medicine analyzer.

Ortho Clinical Diagnostics’ Executive Leader, Jennifer Paine, Recognized by The Regulatory Affairs Professionals Society as a 2015 Top 10 Honoree

Oct 21, 2015

Jennifer Paine, executive vice president of worldwide quality, Regulatory & Compliance, has been recognized by the Regulatory Affairs Professionals Society as a 2015 Top 10 Honoree.

Ortho Clinical Diagnostics Receives CE Mark Clearance for ORTHO VISION™ Max Analyzer for High-Volume Transfusion Medicine Labs

Oct 14, 2015

Ortho Clinical Diagnostics' ORTHO VISION™ Max, a fully automated blood analyzer for high-volume transfusion medicine laboratories, receives CE Mark clearance.

Ortho Clinical Diagnostics Receives 510(k) Clearance for ORTHO VISION™ Analyzer, Making it Commercially Available in the United States

Aug 18, 2015

Ortho Clinical Diagnostics receives 510(k) clearance for ORTHO VISIONTM Analyzer, making it commercially available in the United States.

Ortho Clinical Diagnostics Presents Data on Five Assays in Development at American Association for Clinical Chemistry Annual Meeting

Jul 29, 2015

Ortho Clinical Diagnostics presents data on five assays in development at the American Association for Clinical Chemistry's annual meeting.

Ortho Clinical Diagnostics Receives FDA 510(k) Clearance for VITROS® Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay

Jun 18, 2015

Ortho Clinical Diagnostics receives FDA 510(k) clearance for VITROS® Chemistry Products HbA1c Reagent Kit, an enhanced diabetes testing assay.

Ortho Clinical Diagnostics and Quotient Announce Agreement to Commercialize Innovative Transfusion Medicine Diagnostic Platform, MosaiQ™

Jan 29, 2015

Ortho Clinical Diagnostics and Quotient announce an agreement to commercialize innovative transfusion medicine diagnostic platform MosaiQTM

Ortho Clinical Diagnostics Sponsors AACC Webinar Nov. 19: 'Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury'

Nov 11, 2014

Ortho Clinical Diagnostics sponsors the American Association for Clinical Chemistry webinar: Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury.

Ortho Clinical Diagnostics Receives CE Mark for ORTHO VISION™ Analyzer to take Full Automation Transfusion Medicine Testing to Next Level

Oct 28, 2014

Ortho Clinical Diagnostics receives CE Mark for ORTHO VISION™ Analyzer to take full automation transfusion medicine testing to the next level.

Ortho Clinical Diagnostics Receives CE Mark for VITROS® Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay

Oct 17, 2014

Ortho Clinical Diagnostics receives CE Mark for VITROS® Chemistry Products HbA1c Reagent Kit, an enhanced diabetes testing assay.

Ortho Clinical Diagnostics Signs Agreement with Astute Medical, Inc. to Commercialize and Develop Innovative Acute Kidney Injury Tests

Jul 28, 2014

Ortho Clinical Diagnostics signs agreement with Astute Medical, Inc. to commercialize and develop innovative acute kidney injury tests.

Ortho Clinical Diagnostics, Inc. Announces Executive Leadership Additions as it Becomes an Independent, Stand Alone Company

Jul 8, 2014

Ortho Clinical Diagnostics announces executive leadership appointments as it becomes an independent, stand alone company.

© Ortho Clinical Diagnostics 2019 GmbH Geschäftsführer: Joan Martin, Dean Read, Waclaw Lukowicz HRB Nummer: 33150, Handelsregister: Mannheim Diese Seite wird vom Unternehmen Ortho Clinical Diagnostics GmbH herausgegeben, welches für ihre Inhalte allein verantwortlich ist. Die Produktverfügbarkeit unterliegt der Erfüllung behördlicher Anforderungen auf jedem Markt. Diese Seite wurde nur für medizinische Fachkräfte in Deutschland, Österreich und der Schweiz geschrieben. Zuletzt überarbeitet: 24.08.2017 01:07

${loading}